Can Infused autograft lymphocyte-to-monocyte ratio predict survival in Multiple Myeloma Post autologous peripheral blood hematopoietic stem cell transplantation?

摘要

ABSTRACT The infused autograft lymphocyte-to-monocyte ratio (A-LMR) is a prognostic factor for survival in classical Hodgkin lymphoma (cHL), diffuse large B-cell lymphoma (DLBCL) in addition to T cell lymphoma postautologous peripheral hematopoietic stem cell transplantation (APHSCT). Thus, we check out to investigate if A-LMR is also a prognostic factor for survival post-APHSCT in multiple myeloma (MM).From 2009 to 2015, eighty two MM patients that underwent APHSCT were retrospectively analyze.